[HTML][HTML] Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
…, GJ Young, EI Walsh, RJ Bryant… - … England Journal of …, 2023 - Mass Medical Soc
Background Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and
69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer …
69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer …
Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and …
…, BA Eddy, F Gleeson, R Macpherson, RJ Bryant… - European urology, 2020 - Elsevier
Context : Prebiopsy multiparametric magnetic resonance imaging (mpMRI) is increasingly
used in prostate cancer diagnosis. The reported negative predictive value (NPV) of mpMRI is …
used in prostate cancer diagnosis. The reported negative predictive value (NPV) of mpMRI is …
Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study
RJ Bryant, DD Sjoberg, AJ Vickers… - Journal of the …, 2015 - academic.oup.com
Background: Many men with elevated prostate-specific antigen (PSA) levels in serum do not
have aggressive prostate cancer and undergo unnecessary biopsy. Retrospective studies …
have aggressive prostate cancer and undergo unnecessary biopsy. Retrospective studies …
Patient-reported outcomes 12 years after localized prostate cancer treatment
…, NJ Williams, J Oxley, J Staffurth, RJ Bryant… - NEJM …, 2023 - evidence.nejm.org
Background Long-term patient-reported outcomes are needed to inform treatment decisions
for localized prostate cancer. Methods Patient-reported outcomes of 1643 randomly …
for localized prostate cancer. Methods Patient-reported outcomes of 1643 randomly …
An oncolytic virus expressing a T-cell engager simultaneously targets cancer and immunosuppressive stromal cells
…, A Muntzer, EM Scott, J Hagel, L Campo, RJ Bryant… - Cancer research, 2018 - AACR
An engineered oncolytic adenovirus that encodes a bispecific antibody combines direct
virolysis with endogenous T-cell activation to attack stromal fibroblasts, providing a multimodal …
virolysis with endogenous T-cell activation to attack stromal fibroblasts, providing a multimodal …
[HTML][HTML] The tumor microenvironment and immune responses in prostate cancer patients
JTW Kwon, RJ Bryant… - Endocrine-Related …, 2021 - erc.bioscientifica.com
The landscape of cancer treatment has been transformed over the past decade by the
success of immune-targeting therapies. However, despite sipuleucel-T being the first-ever …
success of immune-targeting therapies. However, despite sipuleucel-T being the first-ever …
[HTML][HTML] Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
Background Radiotherapy enhances innate and adaptive anti-tumour immunity. It is unclear
whether this effect may be harnessed by combining immunotherapy with radiotherapy …
whether this effect may be harnessed by combining immunotherapy with radiotherapy …
Feasibility and safety of radical prostatectomy for oligo‐metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo …
Objectives To test the feasibility of randomisation to radical prostatectomy (RP) plus pelvic
lymphadenectomy in addition to standard‐of‐care (SOC) systemic therapy in men with newly …
lymphadenectomy in addition to standard‐of‐care (SOC) systemic therapy in men with newly …
Local anaesthetic transperineal (LATP) prostate biopsy using a probe‐mounted transperineal access system: a multicentre prospective outcome analysis
…, CE Lovegrove, N Ranasinha, RJ Bryant… - BJU …, 2021 - Wiley Online Library
Objectives To assess the feasibility of local anaesthetic transperineal (LATP) technique
using a single‐freehand transperineal (TP) access device, and report initial prostate cancer (PCa…
using a single‐freehand transperineal (TP) access device, and report initial prostate cancer (PCa…
Comparison of multiparametric magnetic resonance imaging and targeted biopsy with systematic biopsy alone for the diagnosis of prostate cancer: a systematic …
…, SWD Merriel, EWJ Rowe, RJ Bryant… - JAMA network …, 2019 - jamanetwork.com
Importance The current diagnostic pathway for patients with suspected prostate cancer (PCa)
includes prostate biopsy. A large proportion of individuals who undergo biopsy have either …
includes prostate biopsy. A large proportion of individuals who undergo biopsy have either …
